ZA964261B - Prodrugs of paclitaxel derivatives. - Google Patents

Prodrugs of paclitaxel derivatives.

Info

Publication number
ZA964261B
ZA964261B ZA9604261A ZA964261A ZA964261B ZA 964261 B ZA964261 B ZA 964261B ZA 9604261 A ZA9604261 A ZA 9604261A ZA 964261 A ZA964261 A ZA 964261A ZA 964261 B ZA964261 B ZA 964261B
Authority
ZA
South Africa
Prior art keywords
prodrugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
ZA9604261A
Other languages
English (en)
Inventor
Paul M Scola
John F Kadow
Dolatrai M Vyas
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA964261B publication Critical patent/ZA964261B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9604261A 1995-06-06 1996-05-27 Prodrugs of paclitaxel derivatives. ZA964261B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ZA964261B true ZA964261B (en) 1997-11-27

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604261A ZA964261B (en) 1995-06-06 1996-05-27 Prodrugs of paclitaxel derivatives.

Country Status (23)

Country Link
EP (1) EP0747385B1 (xx)
JP (1) JPH08337589A (xx)
KR (1) KR100375956B1 (xx)
CN (1) CN1066151C (xx)
AR (1) AR002756A1 (xx)
AT (1) ATE222259T1 (xx)
AU (1) AU695959B2 (xx)
CA (1) CA2176191A1 (xx)
CZ (1) CZ291516B6 (xx)
DE (1) DE69622933T2 (xx)
DK (1) DK0747385T3 (xx)
ES (1) ES2181824T3 (xx)
HU (1) HUP9601524A3 (xx)
IL (1) IL118526A (xx)
MX (1) MX9601994A (xx)
NO (1) NO315233B1 (xx)
NZ (1) NZ286723A (xx)
PL (1) PL187883B1 (xx)
PT (1) PT747385E (xx)
RU (1) RU2162082C2 (xx)
SG (1) SG72692A1 (xx)
TW (1) TW354293B (xx)
ZA (1) ZA964261B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
PL337064A1 (en) * 1997-05-27 2000-07-31 Baker Norton Pharma Method of and compositions for orally administering taxanes to human beings
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP2002537262A (ja) * 1999-02-18 2002-11-05 オキシジェン，インコーポレイティド 血管破壊のターゲッティングに使用するための組成物および方法
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
JP2003522170A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ７カーボネート置換タキサン
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
JP5139814B2 (ja) * 2005-02-18 2013-02-06 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー 医療装置に結合した改善された疎水性を有した薬剤
MX2015012741A (es) 2013-03-15 2016-02-19 Concert Pharmaceuticals Inc Palbociclib deuterado.
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
JP7110094B2 (ja) * 2015-11-19 2022-08-01 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッド 医薬化合物のアミンプロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9308012A (es) * 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
HUP9601524A3 (en) 2000-03-28
MX9601994A (es) 1997-08-30
NO962231D0 (no) 1996-05-31
ATE222259T1 (de) 2002-08-15
PT747385E (pt) 2002-11-29
EP0747385B1 (en) 2002-08-14
NZ286723A (en) 1998-03-25
AU5471896A (en) 1996-12-19
CN1066151C (zh) 2001-05-23
CA2176191A1 (en) 1996-12-07
EP0747385A1 (en) 1996-12-11
HU9601524D0 (en) 1996-07-29
PL187883B1 (pl) 2004-10-29
DE69622933D1 (de) 2002-09-19
RU2162082C2 (ru) 2001-01-20
TW354293B (en) 1999-03-11
JPH08337589A (ja) 1996-12-24
CN1144805A (zh) 1997-03-12
PL314637A1 (en) 1996-12-09
KR100375956B1 (ko) 2003-04-21
DK0747385T3 (da) 2002-12-16
NO315233B1 (no) 2003-08-04
SG72692A1 (en) 2000-05-23
CZ156396A3 (en) 1996-12-11
HUP9601524A2 (en) 1997-05-28
IL118526A0 (en) 1996-10-16
DE69622933T2 (de) 2003-04-24
ES2181824T3 (es) 2003-03-01
IL118526A (en) 2001-05-20
NO962231L (no) 1996-12-09
AU695959B2 (en) 1998-08-27
CZ291516B6 (cs) 2003-03-12
AR002756A1 (es) 1998-04-29
KR970000222A (ko) 1997-01-21

Similar Documents

Publication Publication Date Title
ZA961444B (en) Pyrazolylbenzoyl derivatives.
GB2306473A8 (en) Glucoxide derivatives
ZA964261B (en) Prodrugs of paclitaxel derivatives.
HU9603071D0 (en) Purin-6-one derivatives
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
HUP9600107A3 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
CY2221B1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
SG48455A1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
IL117989A0 (en) Chromone derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
ZA967741B (en) Diarylalkenylamine derivatives.
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
GB9516349D0 (en) Aza-anthracyclinone derivatives
HU9600213D0 (en) 4-mercapto-benzoyl-guanidine derivatives
ZA964034B (en) N-aminopyridone derivatives.
EP0804205A4 (en) 4-AZA-19-NORANDROSTANDERIVATE
GB9708363D0 (en) Imidazopyridedine derivatives